Transparent Machine Learning Stocks + Digital Assets Forecasts*
If you don't make over $60 your first month, get your money back.
Become a more profitable investor with our transparent AI stock forecasts.
Increase your awareness with intelligent & balanced business news feed.
Stay on top with forecast models models trained, tested, and updated every day.
The news feed designed to reduce addiction and increase your understanding.
We will never sell, rent, or give your personal information away under any circumstance.
* Nothing on this website constitutes investment advice, performance data or any recommendation that any particular security, portfolio of securities, transaction or investment strategy is suitable for any specific person. Helium Trades is not responsible in any way for the accuracy of any model predictions or price data. Any mention of a particular security and related prediction data is not a recommendation to buy or sell that security. Investments in securities involve the risk of loss. Past performance is no guarantee of future results. Helium Trades is not responsible for any of your investment decisions, you should consult a financial expert before engaging in any transaction.
* Nothing on this website constitutes investment advice, performance data or any recommendation that any particular security, portfolio of securities, transaction or investment strategy is suitable for any specific person. Helium Trades is not responsible in any way for the accuracy of any model predictions or price data. Any mention of a particular security and related prediction data is not a recommendation to buy or sell that security. Investments in securities involve the risk of loss. Past performance is no guarantee of future results. Helium Trades is not responsible for any of your investment decisions, you should consult a financial expert before engaging in any transaction.
The blue line is Helium's historical forecast. The black line is the actual closing price. Full transparency of past predictions. Hover over points for more information. Video Tutorial.
Future Price Cone
The future price cone means the model thinks there is a 80% chance the price will land within the bounds of the cone. A blue cone is neutral, a green cone is bullish, and a red cone is bearish.
Model Correlation
Higher (closer to 1) means a more accurate model and lower (closer to -1) means a less accurate model. This is the Spearman Correlation between model predicted percent change and actual percent change calculated over the last 150 days.
Percent Correct (up or down)
This is the percent of the time our models predicted the correct direction of the price (either up or down) over the last 150 days.
Tip:
Left click and drag charts to zoom in. Right click to zoom back out.
* Nothing on this website constitutes investment advice, performance data or any recommendation that any particular security, portfolio of securities, transaction or investment strategy is suitable for any specific person. Helium Trades is not responsible in any way for the accuracy of any model predictions or price data. Any mention of a particular security and related prediction data is not a recommendation to buy or sell that security. Investments in securities involve the risk of loss. Past performance is no guarantee of future results. Helium Trades is not responsible for any of your investment decisions, you should consult a financial expert before engaging in any transaction.
Helium Summary:
The biotechnology sector is experiencing significant growth, driven by advances in AI, gene editing, genomics, and partnerships.
Companies like UNITY Biotechnology and Iovance Biotherapeutics are developing innovative treatments, with UNITY focusing on aging diseases and Iovance on cancer through TIL therapy.
Investments and collaborations, notably GNI Group's $100M fund with Chinese firms, illustrate global and cross-sector engagement.
The sector's expansion includes new facilities and AI integration in drug development [Yahoo][Yahoo][Endpoints].
April 27, 2024
Evidence
Iovance Biotherapeutics employs tumor-infiltrating lymphocyte technology for cancer treatment, highlighting biotech innovation [Yahoo].
GNI Group collaborates with Chinese firms, signifying global investment trends in biotech [Endpoints].
Perspectives
Investor's Perspective
Investors see potential high returns from biotech innovations but are wary of risks like regulatory challenges and market volatility [Yahoo].
Patient's Perspective
Patients could benefit from more effective treatments, but might be concerned about accessibility and costs [Endpoints].
Regulator's Perspective
Regulators focus on ensuring safety and efficacy of new biotechnological advances while managing ethical concerns [biospace.com].
Q&A
How is AI impacting biotech?
AI facilitates faster, more accurate drug discovery, reducing failure rates and costs in biotechnology [genengnews.com]. What are the ethical concerns in biotech?
Issues include gene editing ethics, data privacy in genomics, and the affordability of advanced treatments [biospace.com].
Sources like Yahoo and Biospace often focus on financial and technological aspects of biotech, possibly underestimating ethical and societal implications [Yahoo][biospace.com].
Social Media Perspectives
The discourse on Social Media about the growth of the biotechnology industry captures a spectrum of excitement, optimism, and ethical contemplation.
Many users express enthusiasm about technological innovations, such as mRNA vaccines and advancements that could redefine industries and daily life.
There's a financial buzz too, with investments like Agronomics' $10 million into Liberation Labs highlighting confidence in biotech's economic potential.
Meanwhile, ethical concerns about AI and biotech deepen discussions, stressing the need for thoughtful navigation of these transformative fields.
Users also celebrate educational opportunities, with mentions of university programs and online courses preparing the next wave of biotech experts.
In summary, Social Media reflects a dynamic blend of hope, investment interest, and ethical responsibility in the realm of biotechnology's evolution.
Context
Understanding the biotech boom requires considering the rapid pace of technological progress and its interplay with regulatory frameworks .
Takeaway
The biotechnology boom not only offers hope for advanced medical solutions but also involves considerable market speculations and ethical dilemmas.
Potential Outcomes
Biotech advancements lead to new cancer cures, 15% probability, contingent on successful clinical trials and FDA approvals.
Integration of AI in drug discovery reduces development costs by 30% within five years, 20% probability, dependent on continuing AI advancements and adoption .
* Disclaimer: Nothing on this website constitutes investment advice, performance data or any recommendation that any particular security, portfolio of securities, transaction or investment strategy is suitable for any specific person. Helium Trades is not responsible in any way for the accuracy
of any model predictions or price data. Any mention of a particular security and related prediction data is not a recommendation to buy or sell that security. Investments in securities involve the risk of loss. Past performance is no guarantee of future results. Helium Trades is not responsible for any of your investment decisions,
you should consult a financial expert before engaging in any transaction.
Ask any question about this page!
